Hepatic xenobiotic metabolizing enzyme and transporter gene expression through the life stages of the mouse

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Lee, Janice S ^a,c   Ward, William O ^a   Liu, Jie ^b   Ren, Hongzu ^a   Vallanat, Beena ^a   Delker, Don ^a,d   Corton, J Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; CARRIER PROTEIN; XENOBIOTIC AGENT;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOSENSITIVITY; CONJUGATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIOXIN RECEPTOR GENE; ENVIRONMENTAL EXPOSURE; EXCRETION; FEMALE; FETUS; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENOME ANALYSIS; LIVER METABOLISM; LONG TERM EXPOSURE; MALE; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; NRF2 GENE; NUCLEAR RECEPTOR GENE; ONTOGENY; PREDICTION; RECEPTOR GENE; SEX DIFFERENCE; XENOBIOTIC METABOLISM; ANIMAL; C57BL MOUSE; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; LIFE CYCLE STAGE; LIVER; METABOLISM; MULTIGENE FAMILY; SEXUAL DEVELOPMENT;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIFE CYCLE STAGES; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MULTIGENE FAMILY; SEX CHARACTERISTICS; TRANSCRIPTION, GENETIC; XENOBIOTICS;

EID: 80052524697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024381     Document Type: Article

References (45)

1. Francis GA, Fayard E, Picard F, Auwerx J, (2003) Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
2. Bleasby K, Castle JC, Roberts CJ, Cheng C, Bailey WJ, et al. (2006) Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36: 963-988.
3. Kohle C, Bock KW, (2007) Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 73: 1853-1862.
4. McGrath K, Palis J, (2008) Ontogeny of erythropoiesis in the mammalian embryo. Curr Top Dev Biol 82: 1-22.
5. Spear BT, Jin L, Ramasamy S, Dobierzewska A, (2006) Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell Mol Life Sci 63: 2922-2938.
6. Hakkola J, Pelkonen O, Pasanen M, Raunio H, (1998) Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol 28: 35-72.
7. Hines RN, (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118: 250-267.
8. Schmucker DL, (2005) Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 40: 650-659.
9. Mori K, Blackshear PE, Lobenhofer EK, Parker JS, Orzech DP, et al. (2007) Hepatic transcript levels for genes coding for enzymes associated with xenobiotic metabolism are altered with age. Toxicol Pathol 35: 242-251.
10. Lee JS, Ward WO, Wolf DC, Allen JW, Mills C, et al. (2008) Coordinated changes in xenobiotic metabolizing enzyme gene expression in aging male rats. Toxicol Sci 106: 263-283.
11. Ahlborn GJ, Nelson GM, Grindstaff RD, Waalkes MP, Diwan BA, et al. (2009) Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice. Toxicology 262: 106-113.
12. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
13. Amador-Noguez D, Zimmerman J, Venable S, Darlington G, (2005) Gender-specific alterations in gene expression and loss of liver sexual dimorphism in the long-lived Ames dwarf mice. Biochem Biophys Res Commun 332: 1086-1100.
14. Guo M, Gong L, He L, Lehman-McKeeman L, Wan YJ, (2009) The expression of cancer-related genes in aging mouse liver is RXRα and gender dependent. Advanced Studies in Biology 1: 61-83.
15. Drinkwater NR, Ginsler JJ, (1986) Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 7: 1701-1707.
16. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, et al. (2002) Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 12: 540-550.
17. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, et al. (2002) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-320.
18. Slatter JG, Cheng O, Cornwell PD, de Souza A, Rockett J, et al. (2006) Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and mice in vivo. Xenobiotica 36: 902-937.
19. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, et al. (2006) Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20: 1333-1351.
20. Fujita S, Chiba M, Ohta M, Kitani K, Suzuki T, (1990) Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats. J Pharmacol Exp Ther 253: 369-374.
21. Clodfelter KH, Miles GD, Wauthier V, Holloway MG, Zhang X, et al. (2007) Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol Genomics 31: 63-74.
22. Karanth S, Pope C, (2000) Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol Sci 58: 282-289.
23. Huang H, Fleming CD, Nishi K, Redinbo MR, Hammock BD, (2005) Stereoselective hydrolysis of pyrethroid-like fluorescent substrates by human and other mammalian liver carboxylesterases. Chem Res Toxicol 18: 1371-1377.
24. Barski OA, Tipparaju SM, Bhatnagar A, (2008) The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev 40: 553-624.
25. Fujimori K, Ueno T, Nagata N, Kashiwagi K, Aritake K, et al. (2010) Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J Biol Chem 285: 8880-8886.
26. Wang T, Shah YM, Matsubara T, Zhen Y, Tanabe T, et al. (2010) Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis. J Biol Chem 285: 7670-7685.
27. Endo S, Matsumoto K, Matsunaga T, Ishikura S, Tajima K, et al. (2006) Substrate specificity of a mouse aldo-keto reductase (AKR1C12). Biol Pharm Bull 29: 2488-2492.
28. McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, et al. (2003) Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res 63: 4594-4601.
29. Schroder O, Sjostrom M, Qiu H, Jakobsson PJ, Haeggstrom JZ, (2005) Microsomal glutathione S-transferases: selective up-regulation of leukotriene C4 synthase during lipopolysaccharide-induced pyresis. Cell Mol Life Sci 62: 87-94.
30. Wullschleger S, Loewith R, Hall MN, (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
31. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, et al. (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136: 521-534.
32. Hjelmstrom P, (2001) Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69: 331-339.
33. Singh P, Coskun ZZ, Goode C, Dean A, Thompson-Snipes L, et al. (2008) Lymphoid neogenesis and immune infiltration in aged liver. Hepatology 47: 1680-1690.
34. Broccardo C, Osorio J, Luciani MF, Schriml LM, Prades C, et al. (2001) Comparative analysis of the promoter structure and genomic organization of the human and mouse ABCA7 gene encoding a novel ABCA transporter. Cytogenet Cell Genet 92: 264-270.
35. Mickley L, Jain P, Miyake K, Schriml LM, Rao K, et al. (2001) An ATP-binding cassette gene (ABCG3) closely related to the multidrug transporter ABCG2 (MXR/ABCP) has an unusual ATP-binding domain. Mamm Genome 12: 86-88.
36. Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, et al. (2006) Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21: 437-457.
37. Kensler TW, Wakabayashi N, (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis 31: 90-99.
38. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I, (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414: 91-100.
39. Borlakoglu JT, Scott A, Henderson CJ, Wolf CR, (1993) Alterations in rat hepatic drug metabolism during pregnancy and lactation. Biochem Pharmacol 46: 29-36.
40. Rich KJ, Boobis AR, (1997) Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39: 424-435.
41. Imaoka S, Fujita S, Funae Y, (1991) Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta 1097: 187-192.
42. Czekaj P, Wiaderkiewicz A, Florek E, Wiaderkiewicz R, (2005) Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Arch Toxicol 79: 13-24.
43. He XJ, Yamauchi H, Suzuki K, Ueno M, Nakayama H, et al. (2007) Gene expression profiles of drug-metabolizing enzymes (DMEs) in rat liver during pregnancy and lactation. Exp Mol Pathol 83: 428-434.
44. US EPA (2005a) Guidelines for Carcinogen Risk Assessment.
45. US EPA (2005b) Supplemental Guidance for Assessing Cancer Susceptibility for Early-Life Exposure to Carcinogens.